(Q45259942)
Statements
HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance (English)
Xiaoping Huang
Shuiliang Wang
Choon-Kee Lee
scientific article published on 16 April 2011